Doctors and Patients
 About Us Minimize

The Center for Cancer and Hematologic Disease was founded in 1973 as an outpatient facility in Cherry Hill, New Jersey, specializing in treatment of cancer and diseases of the blood. Since then, we have expanded our facilities to include offices in Woodbury, Washington Township (Sewell), and Hammonton. We have specialists in the areas of Hematology, Medical Oncology, and Gynecologic Oncology who work together to determine the best course of action for each individual patient.

Our staff is dedicated to making your experience here as stress-free and comfortable as possible. Certified nurses, laboratory and pharmacy technicians, pharmacists, and support staff work together with our doctors as a coordinated team to assist you with all aspects of care and treatment. Our state-of-the-art EMR (electronic medical record) system allows doctors and treating nurses to access medical records around the clock. We actively participate in clinical research and ongoing education programs.

The quality of care our patients receive is the guiding principle under which our practice exists. We focus not only on physical health, but also on the emotional well-being of each patient. This is our commitment to you - a commitment to caring.


      

 Divisions Minimize

Our Medical Oncology & Hematology Division has four offices. Our main office is located in Cherry Hill, NJ and we also have offices in Woodbury, Washington Township (Sewell), and Hammonton, NJ. Dr. Norman Siegel, Dr. Howard Kesselheim, Dr. Carlos Madamba, Dr. Richard Greenberg, Dr. Kevin Callahan, Dr. Stephen Zrada, Dr. Yong Ji, and Dr. Priya Gor are Board Certified Medical Oncologists, Hematologists, and Internists. The physicians share in the care of all our patients at all our hospitals, which allows patients to be followed without interruption. Most of our physicians are on staff at Virtua West Jersey, Underwood Memorial Hospital, Our Lady of Lourdes Medical Center, and Kennedy Health System. Dr. Saul is on staff at Cooper Hospital/UMC.

Our Gynecologic Oncology Division in Marlton, NJ is directed by Dr. Howard Saul, a Board Certified Gynecologic Oncologist. Dr. Saul is affiliated with Virtua, Underwood, Our Lady of Lourdes, Kennedy, and Cooper Hospital/UMC.

Learn more about our doctors and staff.


      

 Forms & Articles Minimize

* Some of the links below will open PDF files. To open them, you will need to have the (free) Acrobat Reader installed.

New Patients
Please print this form and bring it with you to your first appointment. If you do not have an appointment yet, please contact us to schedule one prior to completing the packet.

New Patient Packet & Notice of Privacy Practices *

All Patients
Patient Satisfaction Survey *

Gynecologic Oncology
Articles
Ovarian Cancer Article *
Cervical Cancer Article *
Uterine Cancer Article *

Information
Fleet Phospho *
Golytley *
One Day Prep *
Robotic Surgery Information

Medical Oncology

Articles
Personalized Breast Cancer Therapy Replacing One-Size Fits-All Approach *
Carbohydrates: Another Dietary Link for Breast Cancer?


    

 Events

DateEvent


    

   Minimize

COPE Program Information

      

 Announcements Minimize

2011 Awards
Dr. Gor has been recognized as a Top Physician for Women (reader's choice) in SJ Magazine.   read more...
2010 Top Docs
Drs. Siegel, Gor, and Saul have been recognized as "Top Docs" in the latest issue of SJ Magazine.   read more...

      

   Minimize

gazebo.jpg


    

 News Minimize

02/21/2012
FDA Announces Steps to Ease Cancer Drug Shortages
The US Food and Drug Administration (FDA) said Tuesday that it is taking steps to increase the supply of 2 cancer drugs on its drug shortage list: liposomal doxorubicin (Doxil )and methotrexate.

02/16/2012
Manufacturer Releasing Emergency Supplies of Methotrexate
A maker of the cancer drug methotrexate, Bedford Laboratories, has advised the FDA that it will release emergency supplies of preservative-free methotrexate to meet patients’ needs.

02/15/2012
FDA Warns of Counterfeit Avastin
The US Food and Drug Administration (FDA) is warning that some fake versions of the cancer drug Avastin (bevacizumab) may have been purchased by medical practices.


    

Home | Locations | Scheduling | Staff | Clinical Trials Terms Of Use | Privacy Statement
Login